Abstract
Introduction Adolescents living with HIV (ALWH) experience higher mortality rates compared to other age groups, exacerbated by suboptimal transition from pediatric to adult HIV care in which decreased adherence to antiretroviral treatment (ART) and unsuppressed viremia are frequent. Care transition—a process lasting months or years—ideally prepares ALWH for adult care and can be improved by interventions that are youth-friendly and address psychosocial issues affecting ART adherence; however, such interventions are infrequently operationalized. Community-based accompaniment (CBA), in which laypeople provide individualized support and health system navigation, can improve health outcomes among adults with HIV. Here, we describe patient and provider perceptions of a novel HIV CBA intervention called “PASEO” for ALWH in Lima, Peru.
Methods PASEO consisted of six core elements designed to support ALWH before, during, and after transition to adult HIV care. Community-based health workers provided tailored accompaniment for ALWH aged 15-21 years over 9 months, after which adolescent participants were invited to provide feedback in a focus group or in-depth interview. HIV care personnel were also interviewed to understand their perspectives on PASEO. A semi-structured interview guide probing known acceptability constructs was used. Qualitative data were analyzed using a Framework Analysis approach and emergent themes were summarized with illustrative quotes.
Results We conducted 5 focus groups and 11 in-depth interviews among N=26 ALWH and 9 key-informant interviews with HIV care personnel. ALWH participants included those with both vertically- and behaviorally acquired HIV. ALWH praised PASEO, attributing increased ART adherence to the project. Improved mental health, independence, self-acceptance, and knowledge on how to manage their HIV were frequently cited. HIV professionals similarly voiced strong support of PASEO. Both ALWH and HIV professionals expressed hope that PASEO would be scaled. HIV professionals voiced concerns regarding financing PASEO in the future.
Conclusion A multicomponent CBA intervention to increase ART adherence among ALWH in Peru was highly acceptable by ALWH and HIV program personnel. Future research should determine the efficacy and economic impact of the intervention.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.clinicaltrials.gov/ct2/show/NCT05022706?titles=PASEO&draw=2&rank=2
Funding Statement
This study was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R21 AI143365
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Committees of the following institutions gave ethical approval for this work: Hospital Nacional Arzobispo Loayza, Lima, Peru [approval number: 11698]; Instituto Nacional de Salud del Nino, Lima, Peru [approval number: 00213]; Hospital Nacional Hipolito Unanue, Lima, Peru [approval number: 17845]; Harvard Medical School, Boston, United States [approval number: 19-0086]. Written informed consent, including permission to publish study results stripped of personally identifying information, was obtained from adolescents ≥18 years of age and from guardian(s) of adolescents <18 years with informed assent. Consent was waived for adolescents aged <18 years without guardians; they provided informed assent. PASEO was registered with ClinicalTrials.gov (Identifier: NCT05022706).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of authors: JTG: jeromegalea{at}usf.edu
MW: mwong_ses{at}pih.org
BN: bninesling{at}usf.edu
AR: aramos_ses{at}pih.org
LA: lsenador_ses{at}pih.org
HS: hsanchez{at}epicentro.org.pe
LK: lkolevic{at}insn.gob.pe
EM: ematos88{at}hotmail.com
ES: esanchez2018{at}hotmail.com
RE: rerrea_ses{at}pih.org
AL: andrew_lindeborg{at}hms.harvard.edu
CB: cbenites{at}minsa.gob.pe
LL: llecca_ses{at}pih.org
SS: sshin{at}partners.org
MFF: molly_franke{at}hms.harvard.edu
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
